MAPT and Alzheimer disease: Nevertheless, these findings suggest that KL-VSHET+ exerts an APOE ε4-genotype dependent protective effect on CSF Tau and pTau concentrations and on subsequent cognitive decline in older cognitively normal participants susceptible to AD.